Study identifies potential drug treatments for telomere diseases

Capping decades of research, a study in Cell Stem Cell may offer a breakthrough in treating dyskeratosis congenita and other so-called telomere diseases, in which cells age prematurely. Using cells donated by patients, researchers at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center identified several small molecules that appear to rebuild telomere and reverse this cellular aging process.